Christina Kay
2018
In 2018, Christina Kay earned a total compensation of $186.3K as Co, Chief Executive Officer Executive Vice President at Integrated Biopharma, a 3% increase compared to previous year.
Compensation breakdown
Option Awards | $1,543 |
---|---|
Salary | $178,284 |
Other | $6,462 |
Total | $186,289 |
Kay received $178.3K in salary, accounting for 96% of the total pay in 2018.
Kay also received $1.5K in option awards and $6.5K in other compensation.
Rankings
In 2018, Christina Kay's compensation ranked 13,774th out of 14,244 executives tracked by ExecPay. In other words, Kay earned more than 3.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 13,774 | 3rd |
Manufacturing | 5,574 | 3rd |
Chemicals And Allied Products | 2,075 | 3rd |
Drugs | 1,774 | 2nd |
Pharmaceutical Preparations | 1,356 | 3rd |
Kay's colleagues
We found three more compensation records of executives who worked with Christina Kay at Integrated Biopharma in 2018.
News
Integrated Biopharma CFO Dina Masi's 2024 pay rises 8% to $357K
October 28, 2024
Integrated Biopharma CFO Dina Masi's 2023 pay rises 10% to $330K
October 27, 2023
Integrated Biopharma CFO Dina Masi's 2022 pay rises 12% to $300K
October 27, 2022
Integrated Biopharma CFO Dina Masi's 2021 pay rises 6% to $268K
October 27, 2021
Integrated Biopharma CFO Dina Masi's 2019 pay rises 4% to $251K
October 28, 2019